Cargando…

Schizophrenia and COVID-19: risks and recommendations

Detalles Bibliográficos
Autores principales:	Fonseca, Lais, Diniz, Elton, Mendonça, Guilherme, Malinowski, Fernando, Mari, Jair, Gadelha, Ary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Psiquiatria 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236151/ https://www.ncbi.nlm.nih.gov/pubmed/32294689 http://dx.doi.org/10.1590/1516-4446-2020-0010

Ejemplares similares

COVID-19 contamination and severity among patients with schizophrenia: Results from a specialized outpatient clinic survey
por: Costardi, Carlos Gustavo, et al.
Publicado: (2022)

What is the Best Latent Structure of Negative Symptoms in Schizophrenia? A Systematic Review
por: Haguiara, Bernardo, et al.
Publicado: (2021)

The association between adolescent suicide rates and socioeconomic indicators in Brazil: a 10-year retrospective ecological study
por: Jaen-Varas, Denisse, et al.
Publicado: (2019)

Challenges and Insights From Treating Psychotic Disorders During COVID-19 Pandemic in Brazil
por: Gadelha, Ary, et al.
Publicado: (2022)

S24. PATHWAYS LINKING ENVIRONMENTAL RISKS, POLYGENIC RISK SCORE TO SCHIZOPHRENIA AND PSYCHOTIC EXPERIENCES IN A BRAZILIAN COHORT OF CHILDREN AND ADOLESCENTS
por: Fonseca, Lais, et al.
Publicado: (2020)

T117. INVESTIGATION OF FORMAL THOUGHT DISORDER AND RESPONSE TO TREATMENT IN SCHIZOPHRENIA
por: Loures Malinowski, Fernando Rocha, et al.
Publicado: (2018)

O1.4. HOW THE MOST CITED RESEARCH ARTICLES ABOUT SCHIZOPHRENIA IN 2018 DEPICT THE DISEASE?
por: Tonsig, Gabriela, et al.
Publicado: (2020)

Population neuroscience: challenges and opportunities for psychiatric research in low- and middle-income countries
por: Cirillo, Alessandra, et al.
Publicado: (2020)

M200. CLOZAPINE-INDUCED HEPATOTOXICITY: TWO CASE REPORTS
por: Dias, Cintia, et al.
Publicado: (2020)

Linkage Replication for Chromosomal Region 13q32 in Schizophrenia: Evidence from a Brazilian Pilot Study on Early Onset Schizophrenia Families
por: Gadelha, Ary, et al.
Publicado: (2012)

The COVID-19 pandemic: Challenges to prevent suicide in megacities
por: Ziebold, Carolina, et al.
Publicado: (2020)

Evaluation of NDEL1 oligopeptidase activity in blood and brain in an animal model of schizophrenia: effects of psychostimulants and antipsychotics
por: Nani, João V., et al.
Publicado: (2020)

How challenging is to manage agitated patients?
por: Cavalcante, Daniel A., et al.
Publicado: (2019)

Translating science into policy: mental health challenges during the COVID-19 pandemic
por: Mari, Jair J., et al.
Publicado: (2021)

T121. BLUNTED AFFECT EARLY PROGRESSION IN DRUG-NAïVE FIRST EPISODE SCHIZOPHRENIA PATIENTS: 10-WEEK FOLLOW UP
por: Kagan, Simão, et al.
Publicado: (2020)

O12.8. LOWER FAMILY INCOME PREDICTS PSYCHOTIC EXPERIENCES IN A COMMUNITY SAMPLE OF YOUTHS IN BRAZIL: RESULTS FROM A 3-YEAR FOLLOW-UP STUDY
por: Fonseca, Lais, et al.
Publicado: (2018)

Childhood individual and family modifiable risk factors for criminal conviction: a 7-year cohort study from Brazil
por: Ziebold, Carolina, et al.
Publicado: (2022)

S174. POLYENVIRONMENTAL AND POLYGENIC RISK SCORES AND THE EMERGENCE OF PSYCHOTIC EXPERIENCES IN CHILDREN AND ADOLESCENTS
por: Belangero, Sintia, et al.
Publicado: (2020)

T100. NICOTINE USE IMPACTS NEGATIVE SYMPTOMS SEVERITY IN SCHIZOPHRENIA
por: Oliveira, Hianna, et al.
Publicado: (2018)

The anesthesiologist and COVID-19
por: Quintão, Vinícius Caldeira, et al.
Publicado: (2020)

Recommendations for perioperative coronavirus (COVID-19) testing
por: Schwartz, Ruben, et al.
Publicado: (2020)

Our recommendations for acute management of COVID-19
por: Mojoli, Francesco, et al.
Publicado: (2020)

Nutritional Habits and Recommendations in the COVID-19 Era
por: Zampelas, Antonis
Publicado: (2022)

Gene expression over the course of schizophrenia: from clinical high-risk for psychosis to chronic stages
por: Ota, Vanessa Kiyomi, et al.
Publicado: (2019)

The increasing risk of domestic violence, including parricide, during the COVID-19 pandemic: reflections and recommendations
por: Valença, Alexandre M., et al.
Publicado: (2021)

Will Evidence-based Medicine Survive the COVID-19 Pandemic?
por: Serpa Neto, Ary, et al.
Publicado: (2020)

Disparities in Adherence to COVID-19 Public Health Recommendations
por: Weiss, Barry D., et al.
Publicado: (2020)

Challenges and recommendations for cancer care in the COVID-19 pandemic
por: Tian, Jianbo, et al.
Publicado: (2020)

F91. ASSOCIATION BETWEEN SYMPTOM DIMENSIONS AND EXECUTIVE FUNCTION IN SCHIZOPHRENIA
por: Franco, Ana Luiza, et al.
Publicado: (2018)

M184. SOCIAL SKILLS TRAINING FOR TREATMENT-RESISTANT SCHIZOPHRENIA WITH PREDOMINANTLY NEGATIVE SYMPTOMS
por: Kayo, Monica, et al.
Publicado: (2020)

Recommendations for the Management of COVID-19 in Low- and Middle-Income Countries
por: Dondorp, Arjen M., et al.
Publicado: (2021)

Third wave of COVID-19 pandemic in Africa: Challenges and recommendations
por: Hemmeda, Lina, et al.
Publicado: (2022)

PRODH Polymorphisms, Cortical Volumes and Thickness in Schizophrenia
por: Ota, Vanessa K., et al.
Publicado: (2014)

Hikikomori and the COVID-19 pandemic: not leaving behind the socially withdrawn
por: Roza, Thiago H., et al.
Publicado: (2020)

SEPAR recommendations and new challenges on COVID-19 vaccine in respiratory diseases()
por: de la Rosa-Carrillo, D., et al.
Publicado: (2021)

Is semantic verbal fluency impairment explained by executive function deficits in schizophrenia?
por: Berberian, Arthur A., et al.
Publicado: (2016)

Component mechanisms of executive function in schizophrenia and their contribution to functional outcomes
por: Berberian, Arthur A., et al.
Publicado: (2018)

New Insights in the Management of Antipsychotics in the Treatment of Schizophrenia in a Patient with Prolactinoma: A Case Report and Review of the Literature
por: Santos Andrade, Elvis Henrique, et al.
Publicado: (2010)

Recommendations for Metabolic and Bariatric Surgery During the COVID-19 Pandemic from IFSO
por: Yang, Wah, et al.
Publicado: (2020)

WHO Is Recommending against the Use of COVID-19 Convalescent Plasma in Immunocompromised Patients?
por: Franchini, Massimo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5e743bl690fh0r9bki1iirn49e